Genky DrugStores Co., Ltd. (TYO:9267)
Japan · Delayed Price · Currency is JPY 3,625.00
+45.00 (1.26%)
Aug 6, 2026, 10:42 AM JST
Genky DrugStores Cash Flow Statement
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Net Income | 7,875 | 9,902 | 8,803 | 6,704 | 6,083 |
Depreciation & Amortization | 7,133 | 6,292 | 5,566 | 4,955 | 4,592 |
Loss (Gain) From Sale of Assets | 9 | -2 | 287 | 376 | 8 |
Other Operating Activities | -155 | -3,155 | -1,895 | -2,043 | -2,004 |
Change in Accounts Receivable | -830 | -151 | -759 | -1,125 | -198 |
Change in Inventory | -1,583 | -3,042 | -1,603 | -1,579 | -1,522 |
Change in Accounts Payable | 4,122 | 2,877 | 2,197 | 1,799 | -129 |
Change in Other Net Operating Assets | 404 | -124 | 660 | -314 | -754 |
Operating Cash Flow | 16,975 | 12,597 | 13,256 | 8,773 | 6,076 |
Operating Cash Flow Growth | 34.75% | -4.97% | 51.10% | 44.39% | -49.68% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Capital Expenditures | -20,101 | -15,092 | -10,278 | -9,891 | -10,464 |
Sale of Property, Plant & Equipment | 4 | 20 | - | 75 | 45 |
Sale (Purchase) of Intangibles | -42 | -15 | -163 | -37 | -43 |
Investment in Securities | - | - | -3 | - | 35 |
Other Investing Activities | -139 | -531 | -187 | 117 | -161 |
Investing Cash Flow | -20,278 | -15,618 | -10,631 | -9,736 | -10,588 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Long-Term Debt Issued | 14,642 | 13,000 | 10,356 | 11,053 | 9,916 |
Total Debt Issued | 14,642 | 13,000 | 10,356 | 11,053 | 9,916 |
Long-Term Debt Repaid | -9,376 | -9,267 | -12,047 | -9,799 | -7,482 |
Total Debt Repaid | -9,376 | -9,267 | -12,047 | -9,799 | -7,482 |
Net Debt Issued (Repaid) | 5,266 | 3,733 | -1,691 | 1,254 | 2,434 |
Issuance of Common Stock | 77 | 17 | 27 | 3 | 13 |
Common Dividends Paid | -395 | -395 | -380 | -379 | -379 |
Other Financing Activities | -1 | -9 | -14 | -24 | -31 |
Financing Cash Flow | 4,947 | 3,346 | -2,058 | 854 | 2,037 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | -1 | 1 | 1 |
Net Cash Flow | 1,644 | 325 | 566 | -108 | -2,474 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Free Cash Flow | -3,126 | -2,495 | 2,978 | -1,118 | -4,388 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -1.42% | -1.24% | 1.61% | -0.66% | -2.84% |
Free Cash Flow Per Share | -102.30 | -81.92 | 97.91 | -36.79 | -144.36 |
Levered Free Cash Flow | -5,005 | -3,821 | 2,238 | -2,426 | -4,599 |
Unlevered Free Cash Flow | -4,809 | -3,686 | 2,302 | -2,382 | -4,562 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Cash Interest Paid | 306 | 216 | 105 | 71 | 74 |
Cash Income Tax Paid | 2,729 | 3,155 | 1,792 | 2,042 | 1,987 |
Change in Working Capital | 2,113 | -440 | 495 | -1,219 | -2,603 |